ArticleCritical care (London, England)2026
Relationship between negative-pressure ICU rooms and the risk of COVID-19-associated pulmonary aspergillosis: an ancillary analysis of the COVID-ICU cohort study.
Article in Critical care (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Negative-pressure ICU rooms and pulmonary aspergillosis: room conversion matters.Critical care (London, England) · 2026Article
Corrections and comments
- Commented on by
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCOVID-19-associated pulmonary aspergillosis (CAPA) has emerged as a serious complication of severe SARS-CoV-2 pneumonia in critically ill patients requiring invasive mechanical ventilation (IMV). Several host- and treatment-related risk factors have been identified, but the role of environmental factors-particularly ICU room air pressure-remains underexplored.
methodsWe conducted an ancillary analysis of the COVID-ICU study, a prospective multicenter cohort of COVID-19 patients admitted to ICUs in France, Belgium and Switzerland during the first wave of the pandemic. Our analysis included 1233 mechanically ventilated patients. We compared the cumulative incidence of probable invasive pulmonary aspergillosis (IPA), defined according to the 2024 Invasive-Fungal-Diseases-in-Adult-Patients-in-ICU (FUNDICU) consensus criteria, between patients isolated in negative-pressure rooms and those housed in neutral-pressure rooms. Secondary outcomes included the incidence of putative IPA, the incidence of putative IPA or Aspergillus colonization (both defined according to the AspICU algorithm), and the association between probable IPA occurrence and clinical outcomes.
resultsProbable IPA occurred significantly less frequently in patients isolated in negative-pressure rooms, compared to those in neutral-pressure rooms (2.0% vs. 4.8%; adjusted cause-specific hazard ratio [cHR] 0.44, 95%CI 0.21-0.90, p = 0.024). No significant between-group difference was observed in the incidence of putative IPA alone or in combination with Aspergillus colonization (1.3% vs. 2.1%, adjusted cHR 0.65, 95% CI 0.23-1.77, p = 0.4 and 3.3% vs. 5.8%, adjusted cHR 0.66, 95% CI 0.30-1.42, p = 0.29, respectively). The occurrence of probable IPA was associated with longer IMV duration and ICU length-of-stay (adjusted HR 0.45, 95% CI 0.27-0.76, p = 0.002 and 0.59, 95% CI 0.38-0.91, p = 0.017, respectively).
conclusionIn this large multicenter cohort of mechanically ventilated COVID-19 patients, isolation in negative-pressure ICU rooms was associated with a lower incidence of probable IPA, but the small event rate and potential confounders indicate this finding needs to be replicated and validated by other studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.